Ascentage Pharma Group International (AAPG)

AAPG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022
Market Capitalization	1,483	-	-
Enterprise Value	1,566	-	-
Debt / Equity Ratio	2.19	25.42	4.39
Debt / EBITDA Ratio	-	-2.41	-2.32
Debt / FCF Ratio	-2.27	-2.29	-2.01
Quick Ratio	-	1.33	1.76
Interest Coverage	-	-8.71	-15.81
Return on Equity (ROE)	-46.43%	-1310.61%	-216.05%
Return on Assets (ROA)	-	-37.02%	-31.20%
Return on Capital (ROIC)	-14.95%	-49.99%	-40.30%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).